8-K: QT Imaging Holdings Announces 2026 Annual Meeting Results

QT Imaging Holdings, Inc. announced the results of its 2026 Annual Stockholder Meeting, with key votes approving director elections, auditor ratification, and an equity incentive plan amendment.

Summary

• QT Imaging Holdings, Inc. held its 2026 Annual Meeting of Stockholders on July 28, 2026.
• A quorum was established with 8,698,769 shares represented out of 13,768,903 outstanding shares.
• Stockholders elected Professor Zeev Weiner and Bryan Timm as Class II directors until the 2029 Annual Meeting.
• The appointment of BPM LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.
• An amendment to the 2024 Equity Incentive Plan was approved to increase the number of authorized shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it confirms routine corporate governance actions and management's continued support through director elections and equity plan adjustments.

Positives

• Directors Professor Zeev Weiner and Bryan Timm were elected with significant support.
• The appointment of BPM LLP as the independent auditor was ratified with overwhelming approval.
• The amendment to the 2024 Equity Incentive Plan to increase authorized shares was approved.

Future Outlook

The company plans to file the results of the Annual Meeting on Form 8-K with the Securities and Exchange Commission.

Management Comments

• QT Imaging Holdings, Inc. (NASDAQ: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today that at the Annual Meeting of Companys stockholders (the Annual Meeting) held on July 28, 2026, the Companys stockholders voted to approve (i) the election of Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the Companys 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified, (ii) the appointment of BPM LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2026 and (iii) an amendment to the Companys 2024 Equity Incentive Plan to increase the number of shares authorized and reserved for issuance.

Industry Context

StockSavvy.ai notes that this filing is a routine procedural update following an annual stockholder meeting, common for publicly traded medical device companies. The focus on director elections and equity plans reflects standard corporate governance practices.

Management Changes

Corporate Governance

Stakeholder Impact

• Shareholders: Confirmation of board composition and continued ability to incentivize management through equity plans.

Next Steps

• File the results of the Annual Meeting on Form 8-K with the Securities and Exchange Commission.

Key Dates

Keywords

Medical Device, Breast Health, Imaging Technology, Stockholder Meeting, Director Election, Auditor Ratification, Equity Incentive Plan